entertainment -WSS

entertainment

author：leisure time 2025-09-06 03:53:13 - browse：36476

Lung cancer under microscope — coverage from STAT — Lung cancer Adobe

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the design of a key clinical trial.

Delfi also announced that the Merck Global Health Innovation Fund, the VC arm of the drug giant, has made an investment of an undisclosed amount in the company.

Unlike Grail, a unit of Illumina, or Exact Sciences, which seeks to develop a blood test that can be used to screen for multiple types of cancer, Delfi is focusing on a single disease — lung cancer — in which the utility of screening with existing technology is not in dispute. Using low-dose CT scans to detect lung cancer is considered an established technology for people at higher risk of lung cancer. However, far too few people get screened.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

WSS

White House pharmacy plagued with problems, investigation finds

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

The Affordable Care Act has saved billions in health care costs

Supreme Court mifepristone arguments center on docs' right to sue

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Covid vaccine financial winners and losers, from Pfizer to Novavax

explore

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Peter Hotez and the public health issue of online harassment

FDA's naming rule on biosimilars has undermined competition

Activists slam private health insurers over coverage restrictions

Philips to halt sales of sleep apnea machines in U.S.

State Dept. review finds Biden bears some blame for Afghanistan failures

Supreme Court mifepristone arguments center on docs' right to sue

Jerome Adams on the need for new antivirals for Covid

Humana’s losses in Medicare Advantage tank its stock

Wikipedia

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Wegovy leads to weight loss. Can it treat depression, too?

Reconstructing family trees of blood cells may help predict disease

Steward Health Care has deal to sell doctor network to UnitedHealth

New clues to why women have higher risk of autoimmune disorders

How generative AI ratchets up security threats for health systems

focus

knowledge

knowledge

hotspot